During the past decade, Tsentar za kozhno venericheski zaboliavania EOOD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tsentar za kozhno venericheski zaboliavania EOOD" are "Psoriasis" (3 trials). Many other conditions were trialed in "Tsentar za kozhno venericheski zaboliavania EOOD" in a lesser frequency.

Most popular intervention types in "Tsentar za kozhno venericheski zaboliavania EOOD" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (2 trials), "CP 690,550 10 mg" (1 trials), "CP 690,550 5 mg" (1 trials), "Etanercept 50 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tsentar za kozhno venericheski zaboliavania EOOD" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Tsentar za kozhno venericheski zaboliavania EOOD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tsentar za kozhno venericheski zaboliavania EOOD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tsentar za kozhno venericheski zaboliavania EOOD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".